Larson Financial Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $900K | Buy |
8,700
+758
| +10% | +$67.7K | 0.02% | 391 |
|
|
2026
Q1 | $570K | Buy |
7,942
+2,308
| +41% | +$178K | 0.02% | 442 |
|
|
2025
Q4 | $447K | Buy |
5,634
+839
| +17% | +$66.1K | 0.01% | 492 |
|
|
2025
Q3 | $362K | Sell |
4,795
-28
| -0.6% | -$1.92K | 0.01% | 558 |
|
|
2025
Q2 | $333K | Buy |
4,823
+697
| +17% | +$45.7K | 0.01% | 541 |
|
|
2025
Q1 | $280K | Buy |
4,126
+1,141
| +38% | +$68.3K | 0.01% | 552 |
|
|
2024
Q4 | $134K | Sell |
2,985
-557
| -16% | -$31.2K | 0.01% | 662 |
|
|
2024
Q3 | $223K | Buy |
3,542
+2,555
| +259% | +$149K | 0.01% | 547 |
|
|
2024
Q2 | $58.3K | Sell |
987
-6,008
| -86% | -$376K | ﹤0.01% | 775 |
|
|
2024
Q1 | $558K | Buy |
6,995
+543
| +8% | +$41.5K | 0.04% | 226 |
|
|
2023
Q4 | $509K | Buy |
6,452
+5,790
| +875% | +$412K | 0.04% | 218 |
|
|
2023
Q3 | $46.2K | Sell |
662
-1,162
| -64% | -$82.3K | ﹤0.01% | 633 |
|
|
2023
Q2 | $126K | Buy |
1,824
+232
| +15% | +$16.5K | 0.01% | 394 |
|
|
2023
Q1 | $118K | Sell |
1,592
-730
| -31% | -$61.2K | 0.01% | 408 |
|
|
2022
Q4 | $216K | Buy |
2,322
+1,419
| +157% | +$137K | 0.03% | 290 |
|
|
2022
Q3 | $86K | Buy |
903
+171
| +23% | +$16.9K | 0.01% | 377 |
|
|
2022
Q2 | $68K | Sell |
732
-199
| -21% | -$19.4K | 0.01% | 306 |
|
|
2022
Q1 | $94K | Buy |
931
+3
| +0.3% | +$315 | 0.02% | 280 |
|
|
2021
Q4 | $96K | Buy |
928
+197
| +27% | +$18.2K | 0.02% | 279 |
|
|
2021
Q3 | $62K | Buy |
731
+2
| +0.3% | +$168 | 0.01% | 263 |
|
|
2021
Q2 | $61K | Sell |
729
-108
| -13% | -$8.84K | 0.01% | 245 |
|
|
2021
Q1 | $63K | Sell |
837
-27
| -3% | -$1.97K | 0.02% | 221 |
|
|
2020
Q4 | $59K | Buy |
864
+114
| +15% | +$7.42K | 0.02% | 194 |
|
|
2020
Q3 | $44K | Sell |
750
-1,264
| -63% | -$78.7K | 0.02% | 217 |
|
|
2020
Q2 | $131K | Buy |
2,014
+552
| +38% | +$34.8K | 0.06% | 115 |
|
|
2020
Q1 | $87K | Buy |
1,462
+183
| +14% | +$12.2K | 0.05% | 115 |
|
|
2019
Q4 | $95K | Buy |
1,279
+153
| +14% | +$10.7K | 0.05% | 113 |
|
|
2019
Q3 | $71K | Buy |
1,126
+9
| +0.8% | +$533 | 0.05% | 125 |
|
|
2019
Q2 | $61K | Buy |
1,117
+15
| +1% | +$808 | 0.05% | 110 |
|
|
2019
Q1 | $59K | Buy |
1,102
+8
| +0.7% | +$494 | 0.05% | 103 |
|
|
2018
Q4 | $72K | Buy |
+1,094
| New | +$81.7K | 0.07% | 91 |
|
Other funds holding CVS
Larson Financial Group's CVS Position: Q2 2026 in Review
Larson Financial Group increased its CVS Health (CVS) stake by 9.5% in Q2 2026, buying an estimated $67.7K and bringing the position to 8,700 shares worth $900K. The position accounts for 0.02% of the portfolio, ranked #391.
Larson Financial Group first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Larson Financial Group held 8,700 shares of CVS Health worth $900K as of Q2 2026.
- Larson Financial Group bought 758 CVS Health shares in Q2 2026, an estimated $67.7K.
- CVS Health made up 0.02% of Larson Financial Group's portfolio in Q2 2026, its #391 holding.
- Larson Financial Group first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.